Novel therapeutic agents for the treatment of diabetic kidney disease-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Novel therapeutic agents for the treatment of diabetic kidney disease

Published:2020-09-14 Issue:11 Volume:29 Page:1277-1293
ISSN:1354-3784
Container-title:Expert Opinion on Investigational Drugs
language:en
Short-container-title:Expert Opinion on Investigational Drugs

Author:

Hartman Rachel E.¹,Rao P.S.S.²,Churchwell Mariann D.³,Lewis Susan J.⁴

Affiliation:

1. College of Pharmacy, University of Findlay, Findlay, OH, USA

2. Department of Pharmaceutical Science, University of Findlay, Findlay, OH, USA

3. Department of Pharmacy Practice, University of Toledo, Toledo, OH, USA

4. Department of Pharmacy Practice, University of Findlay, Findlay, OH, USA

Publisher

Informa UK Limited

Subject

Pharmacology (medical),Pharmacology,General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/13543784.2020.1811231

Reference173 articles.

1. Epidemiology of Diabetic Kidney Disease

2. Diabetic nephropathy – complications and treatment

3. US Renal Data System 2019 Annual Data Report: Epidemiology of Kidney Disease in the United States

4. Kidney Disease and Increased Mortality Risk in Type 2 Diabetes

5. Diabetic Kidney Disease: Pathophysiology and Therapeutic Targets

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A new perspective on proteinuria and drug therapy for diabetic kidney disease;Frontiers in Pharmacology;2024-07-31

2. AMPK-SP1–Guided Dynein Expression Represents a New Energy-Responsive Mechanism and Therapeutic Target for Diabetic Nephropathy;Kidney360;2024-03-12

3. Protective role of the curcumin derivative, FM0807, in regulating JAK2/STAT3 and TGF-β1/SMAD2/3 signaling pathways in glomerular mesangial cells and renal function in db/db mice;Acta Materia Medica;2024

4. Molecular mechanisms and therapeutic potential of natural flavonoids in diabetic nephropathy: Modulation of intracellular developmental signaling pathways;Current Research in Pharmacology and Drug Discovery;2024

5. Editorial: Diabetic kidney disease: routes to drug development, pharmacology and underlying molecular mechanisms;Frontiers in Pharmacology;2023-08-08

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3